Home
 /
Papers
 /
Biochemistry
 /
MDA5 multimerization on LINE RNA drives pathogenic extracellular immune complexes in autoimmunity
Preprint
Open access
Top 1% · Validated by QED

MDA5 multimerization on LINE RNA drives pathogenic extracellular immune complexes in autoimmunity

Tiffany Hsu, Xi Wang, Yukari Isayama +28 more
January 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.01.27.702129
99
%
QED Score
QED Impressions

By demonstrating that autoantibody binding geometry—not affinity—crosslinks MDA5 filaments into potently immunostimulatory aggregates, this work overturns the assumption that intracellular protein autoantibodies are passive markers and reveals a self-amplifying inflammatory cycle driving dermatomyositis.

Run full QED analysis
Read paper
Save

QED claims analysis

Summary

Anti-MDA5 autoantibodies bind dsRNA-scaffolded MDA5 filaments through convergent epitopes and form extracellular immune complexes that potently activate multiple innate immune pathways including type I interferon signaling, pyroptosis, and NETosis, with LINE retroelement-derived dsRNA serving as the structural scaffold and being further induced by immune complex stimulation to establish a self-amplifying inflammatory cycle that drives anti-MDA5 dermatomyositis pathogenesis.

See full analysis
Main Claim 1 –

Anti-MDA5 mAbs bind MDA5 filaments in two modes

Supporting evidence

  • Germline-encoded residues drive convergent anti-MDA5 epitope recognition
  • Class I bind monomers and filaments; class II prefer filaments
  • Antibody bivalency crosslinks MDA5 filaments into stimulatory aggregates
Main Claim 2 –

Only filamentous MDA5 immune complexes activate innate immunity

Supporting evidence

  • FcγR uptake of filament ICs triggers TLR and RLR signaling
  • Immune activation scales with antibody binding mode and stoichiometry
  • MDA5 filament immune complexes induce macrophage pyroptosis pathways
  • MDA5 filament immune complexes trigger NETosis in human neutrophils
Main Claim 3 –

Plasma MDA5 filament immune complexes track anti-MDA5 DM activity

Supporting evidence

  • TRIM65 sandwich ELISA selectively detects filamentous over monomeric MDA5
Main Claim 4 –

LINE-derived dsRNA scaffolds MDA5 filament formation in patients

Supporting evidence

  • LINE dsRNA shows sense-antisense balance and A-to-I editing
  • Host gene transcription drives LINE RNA expression in anti-MDA5 DM

Abstract

Autoantibodies are hallmarks of many autoimmune diseases, but their potential pathogenic roles, particularly for those targeting intracellular proteins, remain unclear. Anti-MDA5-positive dermatomyositis (anti-MDA5 DM) is characterized by autoantibodies against the intracellular protein MDA5, a conserved innate immune receptor that recognizes viral dsRNA by forming filaments. Here, using four patient-derived monoclonal autoantibodies (mAbs), we reconstitute and define the molecular architecture, biogenesis, and immunological activity of pathogenic MDA5 immune complexes. Our cryo-EM analysis revealed that these mAbs bind dsRNA-scaffolded MDA5 filaments in at least two distinct binding modes, each exhibiting striking epitope convergence. Extracellular immune complexes formed between mAbs and filamentous, but not monomeric, MDA5 potently activate multiple innate immune pathways, with the magnitude of activation determined by antibody binding mode and immune-complex stoichiometry. Antibody bivalency further crosslinks MDA5 filaments into higher-order aggregates with heightened immunostimulatory activity, demonstrating an active role of autoantibodies in shaping immune complex architecture. Analysis of patient plasma reveals elevated levels of extracellular MDA5 filaments and identifies LINE retroelement-derived dsRNA as a structural scaffold. Notably, MDA5 immune complexes induce endogenous LINE dsRNA expression, likely promoting additional MDA5 filament formation and extracellular release through inflammatory cell death. These data thus support a self-amplifying inflammatory cycle as a pathogenic mechanism for anti-MDA5 DM. Collectively, our study defines a broadly applicable architectural principle, in which higher-order organization and binding modes of autoantibodies––beyond antibody affinity or nucleic acid presence alone––govern innate immune activation.

Related papers

How the QED Score works

QED Score is an AI-based quality metric for life science research. It rates each paper on two dimensions: originality (is the finding new and important?) and validity (does the evidence support the claims?). Author names and affiliations are removed before scoring. Each manuscript is broken down into its claims and the experiments behind them, and specialized AI agents then examine those claims for statistical rigor, consistency across figures, and contradictions with the existing literature. A verification layer re-checks every issue they flag. Scores are percentile ranks against all papers in the corpus. In a blinded study of papers where QED Score and journal rank disagreed, domain experts sided with QED Score in 75% of cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?